Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 208,812 | 433,970 | 158,461 | 123,287 | 288,028 |
| Marketable Securities | 894,838 | 707,049 | 340,430 | 472,572 | 398,535 |
| Receivables | 69,929 | 56,786 | 53,644 | 52,623 | 55,538 |
| Inventories | 18,697 | 19,481 | 18,373 | 19,133 | 19,285 |
| TOTAL | $1,231,745 | $1,244,174 | $605,024 | $691,922 | $779,284 |
| Non-Current Assets | |||||
| PPE Net | 33,831 | 28,141 | 26,806 | 26,169 | 21,549 |
| Intangibles | 797,669 | 794,877 | 791,155 | 787,635 | 792,841 |
| Other Non-Current Assets | 145,033 | 113,867 | 53,652 | 39,866 | 30,108 |
| TOTAL | $976,533 | $936,885 | $871,613 | $853,670 | $844,498 |
| Total Assets | $2,208,278 | $2,181,059 | $1,476,637 | $1,545,592 | $1,623,782 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,023 | 22,159 | 18,333 | 20,000 | 20,000 |
| Accounts payable and accrued liabilities | 242,168 | 218,561 | 166,760 | 185,386 | 199,276 |
| Other current liabilities | 1,250 | 0 | 4,868 | 3,644 | 3,186 |
| TOTAL | $277,333 | $253,822 | $201,843 | $217,668 | $235,857 |
| Non-Current Liabilities | |||||
| Long Term Debt | 967,884 | 945,070 | 297,029 | 294,574 | 293,859 |
| Deferred Revenues | 4,151 | 5,992 | 7,702 | 8,638 | 8,242 |
| Other Non-Current Liabilities | 321,291 | 317,742 | 252,378 | 371,986 | 365,459 |
| TOTAL | $1,448,963 | $1,416,283 | $702,300 | $799,190 | $793,595 |
| Total Liabilities | $1,726,296 | $1,670,105 | $904,143 | $1,016,858 | $1,029,452 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,322 | 68,236 | 67,703 | 62,875 | 62,633 |
| Common Shares | 70 | 68 | 67 | 62 | 62 |
| Retained earnings | -1,628,877 | -1,554,523 | -1,484,831 | -1,303,404 | -1,190,499 |
| Other shareholders' equity | -60,957 | -35,727 | -10,016 | -1,985 | -10,584 |
| TOTAL | $481,982 | $510,954 | $572,494 | $528,734 | $594,330 |
| Total Liabilities And Equity | $2,208,278 | $2,181,059 | $1,476,637 | $1,545,592 | $1,623,782 |